Harmony Biosciences Holdings (HRMY) Net Cash Flow (QoQ) (2020 - 2026)
Harmony Biosciences Holdings (HRMY) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -254.60% |
| Dec 31, 2025 | 4.51% |
| Sep 30, 2025 | 76.94% |
| Jun 30, 2025 | 58.49% |
| Mar 31, 2025 | -45.15% |
| Dec 31, 2024 | -6.33% |
| Sep 30, 2024 | 546.74% |
| Jun 30, 2024 | -173.57% |
| Mar 31, 2024 | 264.98% |
| Dec 31, 2023 | -279.79% |
| Sep 30, 2023 | -75.17% |
| Jun 30, 2023 | -34.46% |
| Mar 31, 2023 | 351.60% |
| Dec 31, 2022 | -170.77% |
| Sep 30, 2022 | 106.17% |
| Jun 30, 2022 | 222.67% |
| Mar 31, 2022 | -121.99% |
| Dec 31, 2021 | 48.59% |
| Sep 30, 2021 | 62.11% |
| Jun 30, 2021 | 121.17% |